| Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy DA Knorr, Z Ni, D Hermanson, MK Hexum, L Bendzick, LJN Cooper, ... Stem cells translational medicine 2 (4), 274-283, 2013 | 413 | 2013 |
| Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity PS Woll, B Grzywacz, X Tian, RK Marcus, DA Knorr, MR Verneris, ... Blood, The Journal of the American Society of Hematology 113 (24), 6094-6101, 2009 | 301 | 2009 |
| Tumor necrosis factor‐α‐induced neutral sphingomyelinase‐2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors D Wheeler, E Knapp, VVR Bandaru, Y Wang, D Knorr, C Poirier, ... Journal of neurochemistry 109 (5), 1237-1249, 2009 | 233 | 2009 |
| Clinical utility of natural killer cells in cancer therapy and transplantation DA Knorr, V Bachanova, MR Verneris, JS Miller Seminars in immunology 26 (2), 161-172, 2014 | 217 | 2014 |
| Pharmacologic modulation of RNA splicing enhances anti-tumor immunity SX Lu, E De Neef, JD Thomas, E Sabio, B Rousseau, M Gigoux, DA Knorr, ... Cell 184 (15), 4032-4047. e31, 2021 | 206 | 2021 |
| RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells D Ran, WJ Shia, MC Lo, JB Fan, DA Knorr, PI Ferrell, Z Ye, M Yan, ... Blood, The Journal of the American Society of Hematology 121 (15), 2882-2890, 2013 | 158 | 2013 |
| COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia LE Roeker, DA Knorr, MC Thompson, M Nivar, S Lebowitz, N Peters, ... Leukemia 35 (9), 2703-2705, 2021 | 154 | 2021 |
| Expression of Chimeric Receptor CD4ζ by Natural Killer Cells Derived from Human Pluripotent Stem Cells Improves In Vitro Activity but Does Not Enhance … Z Ni, DA Knorr, L Bendzick, J Allred, DS Kaufman Stem cells 32 (4), 1021-1031, 2014 | 126 | 2014 |
| Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms Z Ni, DA Knorr, CL Clouser, MK Hexum, P Southern, LM Mansky, IH Park, ... Journal of virology 85 (1), 43-50, 2011 | 113 | 2011 |
| Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia LE Roeker, DA Knorr, MS Pessin, LV Ramanathan, MC Thompson, ... Leukemia 34 (11), 3047-3049, 2020 | 99 | 2020 |
| Toxicity of an Fc-engineered anti-CD40 antibody is abrogated by intratumoral injection and results in durable antitumor immunity DA Knorr, R Dahan, JV Ravetch Proceedings of the National Academy of Sciences 115 (43), 11048-11053, 2018 | 87 | 2018 |
| Pluripotent stem cell-derived natural killer cells for cancer therapy DA Knorr, DS Kaufman Translational Research 156 (3), 147-154, 2010 | 77 | 2010 |
| Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model MA Geller, DA Knorr, DA Hermanson, L Pribyl, L Bendzick, V Mccullar, ... Cytotherapy 15 (10), 1297-1306, 2013 | 75 | 2013 |
| Disease-and therapy-specific impact on humoral immune responses to COVID-19 vaccination in hematologic malignancies DJ Chung, GL Shah, SM Devlin, LV Ramanathan, S Doddi, MS Pessin, ... Blood cancer discovery 2 (6), 568-576, 2021 | 72 | 2021 |
| Development, expansion, and in vivo monitoring of human NK cells from human embryonic stem cells (hESCs) and and induced pluripotent stem cells (iPSCs) AM Bock, D Knorr, DS Kaufman Journal of visualized experiments: JoVE, 50337, 2013 | 62 | 2013 |
| Dendritic cell targeting with Fc-enhanced CD40 antibody agonists induces durable antitumor immunity in humanized mouse models of bladder cancer CS Garris, JL Wong, JV Ravetch, DA Knorr Science translational medicine 13 (594), eabd1346, 2021 | 60 | 2021 |
| MMP-7 cleaves the NR1 NMDA receptor subunit and modifies NMDA receptor function A Szklarczyk, O Ewaleifoh, JC Beique, Y Wang, D Knorr, N Haughey, ... The FASEB Journal 22 (11), 3757, 2008 | 60 | 2008 |
| Predictors of humoral response to SARS-CoV-2 vaccination after hematopoietic cell transplantation and CAR T-cell therapy R Tamari, I Politikos, DA Knorr, SA Vardhana, JC Young, LAT Marcello, ... Blood Cancer Discovery 2 (6), 577-585, 2021 | 59 | 2021 |
| PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine RS Herati, DA Knorr, LA Vella, LV Silva, L Chilukuri, SA Apostolidis, ... Nature immunology 23 (8), 1183-1192, 2022 | 57 | 2022 |
| Hematopoietic and nature killer cell development from human pluripotent stem cells Z Ni, DA Knorr, DS Kaufman Embryonic Stem Cell Immunobiology: Methods and Protocols, 33-41, 2013 | 39 | 2013 |
